166 related articles for article (PubMed ID: 16611065)
1. Sphingolipids in anticancer therapy.
Padrón JM
Curr Med Chem; 2006; 13(7):755-70. PubMed ID: 16611065
[TBL] [Abstract][Full Text] [Related]
2. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Gatt S; Dagan A
Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
[TBL] [Abstract][Full Text] [Related]
3. Synthetic, non-natural sphingolipid analogs inhibit the biosynthesis of cellular sphingolipids, elevate ceramide and induce apoptotic cell death.
Dagan A; Wang C; Fibach E; Gatt S
Biochim Biophys Acta; 2003 Sep; 1633(3):161-9. PubMed ID: 14499735
[TBL] [Abstract][Full Text] [Related]
4. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipids as Regulators of Autophagy and Endocytic Trafficking.
Young MM; Wang HG
Adv Cancer Res; 2018; 140():27-60. PubMed ID: 30060813
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipid signaling in epidermal homeostasis. Current knowledge and new therapeutic approaches in dermatology.
Geilen CC; Barz S; Bektas M
Skin Pharmacol Appl Skin Physiol; 2001; 14(5):261-71. PubMed ID: 11586067
[TBL] [Abstract][Full Text] [Related]
8. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
[TBL] [Abstract][Full Text] [Related]
9. The unfolding role of ceramide in coordinating retinoid-based cancer therapy.
Ghandour B; Dbaibo G; Darwiche N
Biochem J; 2021 Oct; 478(19):3621-3642. PubMed ID: 34648006
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipid players in the leukemia arena.
Ricci C; Onida F; Ghidoni R
Biochim Biophys Acta; 2006 Dec; 1758(12):2121-32. PubMed ID: 16904628
[TBL] [Abstract][Full Text] [Related]
11. Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond.
Loh KC; Baldwin D; Saba JD
Anticancer Agents Med Chem; 2011 Nov; 11(9):782-93. PubMed ID: 21707493
[TBL] [Abstract][Full Text] [Related]
12. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate.
Gomez-Muñoz A; Presa N; Gomez-Larrauri A; Rivera IG; Trueba M; Ordoñez M
Prog Lipid Res; 2016 Jan; 61():51-62. PubMed ID: 26703189
[TBL] [Abstract][Full Text] [Related]
13. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
Huwiler A; Pfeilschifter J
Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
[TBL] [Abstract][Full Text] [Related]
14. Anticancer compounds and sphingolipid metabolism in the colon.
Duan RD
In Vivo; 2005; 19(1):293-300. PubMed ID: 15796189
[TBL] [Abstract][Full Text] [Related]
15. Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs.
Lai MK; Chew WS; Torta F; Rao A; Harris GL; Chun J; Herr DR
Neuromolecular Med; 2016 Sep; 18(3):396-414. PubMed ID: 27393119
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipids and response to chemotherapy.
Dimanche-Boitrel MT; Rebillard A
Handb Exp Pharmacol; 2013; (216):73-91. PubMed ID: 23563652
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine kinase-1--a potential therapeutic target in cancer.
Cuvillier O
Anticancer Drugs; 2007 Feb; 18(2):105-10. PubMed ID: 17159597
[TBL] [Abstract][Full Text] [Related]
18. [Sphingolipid-mediated apoptotic signaling pathways].
Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipid metabolism, apoptosis and resistance to cytotoxic agents: can we interfere?
Rizzieri KE; Hannun YA
Drug Resist Updat; 1998; 1(6):359-76. PubMed ID: 17092818
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic effects of dietary and synthetic sphingolipids in androgen-independent (PC-3) prostate cancer cells.
Kent KD; Clubbs EA; Harper WJ; Bomser JA
Lipids; 2008 Feb; 43(2):143-9. PubMed ID: 18188632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
